Alpha 2.0
Login Register
» Articles » PMID: 11455793

New Antimalarial Treatment for KwaZulu-Natal

Overview
Journal S Afr Med J
Specialty General Medicine
Date 2001 Jul 18
PMID 11455793
Citations 4
Authors
L Baker
K Barnes
Affiliations
Soon will be listed here.
Citing Articles

Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).

Raman J, Kagoro F, Mabuza A, Malatje G, Reid A, Frean J Malar J. 2019; 18(1):280.

PMID: 31438951 PMC: 6704579. DOI: 10.1186/s12936-019-2911-y.

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.

Sipilanyambe N, Simon J, Chanda P, Olumese P, Snow R, Hamer D Malar J. 2008; 7:25.

PMID: 18230140 PMC: 2248595. DOI: 10.1186/1475-2875-7-25.

Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.

Barnes K, Durrheim D, Little F, Jackson A, Mehta U, Allen E PLoS Med. 2005; 2(11):e330.

PMID: 16187798 PMC: 1240068. DOI: 10.1371/journal.pmed.0020330.

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether.

Sutherland C, Ord R, Dunyo S, Jawara M, Drakeley C, Alexander N PLoS Med. 2005; 2(4):e92.

PMID: 15839740 PMC: 1087200. DOI: 10.1371/journal.pmed.0020092.